US Stock MarketDetailed Quotes

OKYO OKYO Pharma

Watchlist
  • 1.160
  • +0.090+8.41%
Close Dec 27 16:00 ET
  • 1.160
  • 0.0000.00%
Post 20:01 ET
39.25MMarket Cap-2.04P/E (TTM)

OKYO Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(FY)Mar 31, 2023
(FY)Mar 31, 2022
(FY)Mar 31, 2021
(FY)Mar 31, 2020
(FY)Mar 31, 2019
(FY)Mar 31, 2018
(FY)Mar 31, 2017
(FY)Mar 31, 2016
(FY)Mar 31, 2015
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-23.33%-9.49M
-40.73%-7.7M
-241.71%-5.47M
-33.12%-1.6M
39.59%-1.2M
-24.77%-1.99M
-144.89%-1.59M
-0.06%-651.27K
91.85%-650.88K
-131.16%-7.98M
Net income from continuing operations
-26.49%-16.8M
-113.65%-13.28M
-84.03%-6.22M
-108.50%-3.38M
66.95%-1.62M
82.66%-4.9M
-11,584.05%-28.27M
70.50%-241.93K
90.06%-820.17K
40.72%-8.26M
Operating gains losses
7.80%55.18K
644.07%51.19K
-390.58%-9.41K
-76.73%3.24K
1,292.03%13.92K
-100.00%-1.17K
--26.39M
----
-127.31%-26.9K
77.71%98.48K
Depreciation and amortization
1.82%3.87K
62.89%3.8K
-82.22%2.33K
119.28%13.11K
2,644.97%5.98K
--217.8166
--0
----
----
----
Other non cash items
2,912.53%3.46M
86.31%114.99K
-25.64%61.72K
93.73%83.01K
-98.40%42.85K
991.02%2.69M
--246.21K
----
28.53%-12.36K
-517.57%-17.29K
Change In working capital
-32.35%2.67M
485.38%3.95M
-197.99%-1.02M
460.14%1.04M
5.50%186.53K
395.04%176.81K
108.35%35.72K
-491.19%-427.71K
246.35%109.34K
-34.37%-74.71K
-Change in receivables
--0
--0
-86.65%27.38K
267.09%205.07K
6.41%-122.73K
-165.98%-131.14K
155.03%198.76K
-584.16%-361.21K
1,536.60%74.61K
94.94%-5.19K
-Change in payables and accrued expense
-41.00%2.23M
1,616.75%3.78M
-129.66%-249.09K
171.54%839.78K
0.43%309.27K
288.88%307.95K
-145.16%-163.04K
-291.48%-66.51K
149.96%34.73K
-247.53%-69.52K
-Change in other current assets
162.50%440.26K
120.91%167.72K
---802.15K
----
----
----
----
----
----
----
Cash from discontinued investing activities
0
6.56M
Operating cash flow
-23.33%-9.49M
-40.73%-7.7M
-241.71%-5.47M
-33.12%-1.6M
39.59%-1.2M
-24.77%-1.99M
-144.89%-1.59M
-0.06%-651.27K
54.08%-650.88K
58.95%-1.42M
Investing cash flow
Cash flow from continuing investing activities
0
-254.46%-5.92K
90.79%-1.67K
86.35%-18.11K
-9,931.22%-132.67K
-1.32K
0
87.85%-335.18K
73.95%-2.76M
Capital expenditure reported
----
----
----
----
----
----
----
----
85.28%-405.59K
73.48%-2.75M
Net PPE purchase and sale
--0
-254.46%-5.92K
75.96%-1.67K
---6.94K
--0
---1.32K
--0
----
1,552.67%70.41K
97.67%-4.85K
Net other investing changes
----
----
----
91.58%-11.17K
---132.67K
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
-254.46%-5.92K
90.79%-1.67K
86.35%-18.11K
-9,931.22%-132.67K
---1.32K
--0
----
87.85%-335.18K
73.95%-2.76M
Financing cash flow
Cash flow from continuing financing activities
-33.41%6.21M
332.99%9.32M
-72.49%2.15M
712.50%7.83M
963.31K
0
-96.66%12.36K
-96.45%370.51K
Net issuance payments of debt
--0
--2M
--0
27,839.94%7.58M
---27.33K
--0
----
----
-28.53%12.36K
--17.29K
Net common stock issuance
-15.22%6.21M
--7.32M
--0
-76.78%230.02K
--990.64K
--0
----
----
----
----
Proceeds from stock option exercised by employees
--0
--0
13,468.18%2.15M
--15.87K
--0
----
----
----
----
56.50%353.22K
Cash from discontinued financing activities
Financing cash flow
-33.41%6.21M
332.99%9.32M
-72.49%2.15M
712.50%7.83M
--963.31K
--0
----
----
-96.66%12.36K
-96.45%370.51K
Net cash flow
Beginning cash position
49.79%4.05M
-60.80%2.7M
2,825.59%6.89M
-62.48%235.49K
-76.03%627.62K
-40.60%2.62M
0.23%4.41M
-29.89%4.4M
-40.36%6.27M
-33.03%10.52M
Current changes in cash
-302.32%-3.28M
148.91%1.62M
-153.42%-3.32M
1,771.58%6.21M
81.35%-371.42K
-24.85%-1.99M
-144.89%-1.59M
33.11%-651.27K
74.42%-973.71K
-5.32%-3.81M
Effect of exchange rate changes
122.88%63.5K
68.18%-277.54K
-295.89%-872.14K
2,249.98%445.22K
---20.71K
----
----
--0
30.64%-171.84K
8.21%-247.75K
End cash Position
-79.56%826.85K
49.79%4.05M
-60.80%2.7M
2,825.59%6.89M
-62.48%235.49K
-77.70%627.56K
-24.91%2.81M
-26.93%3.75M
-20.67%5.13M
-45.32%6.47M
Free cash flow
-23.24%-9.49M
-40.80%-7.7M
-240.34%-5.47M
-33.70%-1.61M
39.63%-1.2M
-24.85%-1.99M
-144.89%-1.59M
38.38%-651.27K
74.70%-1.06M
70.38%-4.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(FY)Mar 31, 2024(FY)Mar 31, 2023(FY)Mar 31, 2022(FY)Mar 31, 2021(FY)Mar 31, 2020(FY)Mar 31, 2019(FY)Mar 31, 2018(FY)Mar 31, 2017(FY)Mar 31, 2016(FY)Mar 31, 2015
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -23.33%-9.49M-40.73%-7.7M-241.71%-5.47M-33.12%-1.6M39.59%-1.2M-24.77%-1.99M-144.89%-1.59M-0.06%-651.27K91.85%-650.88K-131.16%-7.98M
Net income from continuing operations -26.49%-16.8M-113.65%-13.28M-84.03%-6.22M-108.50%-3.38M66.95%-1.62M82.66%-4.9M-11,584.05%-28.27M70.50%-241.93K90.06%-820.17K40.72%-8.26M
Operating gains losses 7.80%55.18K644.07%51.19K-390.58%-9.41K-76.73%3.24K1,292.03%13.92K-100.00%-1.17K--26.39M-----127.31%-26.9K77.71%98.48K
Depreciation and amortization 1.82%3.87K62.89%3.8K-82.22%2.33K119.28%13.11K2,644.97%5.98K--217.8166--0------------
Other non cash items 2,912.53%3.46M86.31%114.99K-25.64%61.72K93.73%83.01K-98.40%42.85K991.02%2.69M--246.21K----28.53%-12.36K-517.57%-17.29K
Change In working capital -32.35%2.67M485.38%3.95M-197.99%-1.02M460.14%1.04M5.50%186.53K395.04%176.81K108.35%35.72K-491.19%-427.71K246.35%109.34K-34.37%-74.71K
-Change in receivables --0--0-86.65%27.38K267.09%205.07K6.41%-122.73K-165.98%-131.14K155.03%198.76K-584.16%-361.21K1,536.60%74.61K94.94%-5.19K
-Change in payables and accrued expense -41.00%2.23M1,616.75%3.78M-129.66%-249.09K171.54%839.78K0.43%309.27K288.88%307.95K-145.16%-163.04K-291.48%-66.51K149.96%34.73K-247.53%-69.52K
-Change in other current assets 162.50%440.26K120.91%167.72K---802.15K----------------------------
Cash from discontinued investing activities 06.56M
Operating cash flow -23.33%-9.49M-40.73%-7.7M-241.71%-5.47M-33.12%-1.6M39.59%-1.2M-24.77%-1.99M-144.89%-1.59M-0.06%-651.27K54.08%-650.88K58.95%-1.42M
Investing cash flow
Cash flow from continuing investing activities 0-254.46%-5.92K90.79%-1.67K86.35%-18.11K-9,931.22%-132.67K-1.32K087.85%-335.18K73.95%-2.76M
Capital expenditure reported --------------------------------85.28%-405.59K73.48%-2.75M
Net PPE purchase and sale --0-254.46%-5.92K75.96%-1.67K---6.94K--0---1.32K--0----1,552.67%70.41K97.67%-4.85K
Net other investing changes ------------91.58%-11.17K---132.67K--------------------
Cash from discontinued investing activities
Investing cash flow --0-254.46%-5.92K90.79%-1.67K86.35%-18.11K-9,931.22%-132.67K---1.32K--0----87.85%-335.18K73.95%-2.76M
Financing cash flow
Cash flow from continuing financing activities -33.41%6.21M332.99%9.32M-72.49%2.15M712.50%7.83M963.31K0-96.66%12.36K-96.45%370.51K
Net issuance payments of debt --0--2M--027,839.94%7.58M---27.33K--0---------28.53%12.36K--17.29K
Net common stock issuance -15.22%6.21M--7.32M--0-76.78%230.02K--990.64K--0----------------
Proceeds from stock option exercised by employees --0--013,468.18%2.15M--15.87K--0----------------56.50%353.22K
Cash from discontinued financing activities
Financing cash flow -33.41%6.21M332.99%9.32M-72.49%2.15M712.50%7.83M--963.31K--0---------96.66%12.36K-96.45%370.51K
Net cash flow
Beginning cash position 49.79%4.05M-60.80%2.7M2,825.59%6.89M-62.48%235.49K-76.03%627.62K-40.60%2.62M0.23%4.41M-29.89%4.4M-40.36%6.27M-33.03%10.52M
Current changes in cash -302.32%-3.28M148.91%1.62M-153.42%-3.32M1,771.58%6.21M81.35%-371.42K-24.85%-1.99M-144.89%-1.59M33.11%-651.27K74.42%-973.71K-5.32%-3.81M
Effect of exchange rate changes 122.88%63.5K68.18%-277.54K-295.89%-872.14K2,249.98%445.22K---20.71K----------030.64%-171.84K8.21%-247.75K
End cash Position -79.56%826.85K49.79%4.05M-60.80%2.7M2,825.59%6.89M-62.48%235.49K-77.70%627.56K-24.91%2.81M-26.93%3.75M-20.67%5.13M-45.32%6.47M
Free cash flow -23.24%-9.49M-40.80%-7.7M-240.34%-5.47M-33.70%-1.61M39.63%-1.2M-24.85%-1.99M-144.89%-1.59M38.38%-651.27K74.70%-1.06M70.38%-4.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes--------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data